Loading ...

Fast insight into nanotechnology

Access easily searchable nanoscience data, synthesis methods and literature

human coagulation factor IX R338A mRNA-encapsulated lipid enabled and unlocked nucleic acid modified RNA nanoparticles

Based on

1 Articles
2017 Most recent source

Composition

Image only illustrates the order and placement of components as described in literature.

1

lipid composition

Type Complex Compound
Formula
Role carriers
2

human Factor IX protein R338A messenger mRNA

hFIX mRNA R338A
Type Biomolecule
Formula
Role loaded material

Properties

Applications

Area Application Nanomaterial Variant Source
medicine/veterinary

More information available to subscribers only.

Or, view sample content

Characterization

Biological effects

Biological system Test details Nanomaterial Variant Source
coagulation factor IX-deficient (FIX<sup>-/-</sup>) hemophilic mouse

More information/entries available to subscribers only.

Or, view sample content

Preparation

Method 1

Type: Chemical synthesis
Source:
Starting materials
  • di((Z)-non-2-en-1-yl) 8,8'-((((2-(dimethylamino)ethyl)thio)carbonyl)azanediyl)dioctanoate
  • cholesterol
  • 1,2-dimyristoyl-sn-glycerol methoxypolyethylene glycol
See all (5)
  1. 9UN1TVdesbWdzTNpibOjdqNenl6IP8lQu9ro9xuMV
  2. sVMta6
Product

human coagulation factor IX R338A mRNA-encapsulated lipid enabled and unlocked nucleic acid modified RNA nanoparticles

Size: not specified

Medium/Support: none

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial